Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2009-05-19

FDA Approved: ADVIL PM — Supplemental Application (Haleon US Holdings LLC)

View source ↗

Summary

FDA approved a supplemental application for Advil PM (diphenhydramine HCl and ibuprofen) submitted by Haleon US Holdings LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ADVIL PM (DIPHENHYDRAMINE HCL; IBUPROFEN)

Snippet

SUPPL AP for ADVIL PM (DIPHENHYDRAMINE HCL, IBUPROFEN)